Epic editorial just published in @jrheum re:@ACRheum 2019 osteoarthritis recommendations
In short, ACR took the (correct!) stance that we should recommend AGAINST hyaluronic acid
This somewhat understandably upset companies that produce this voodoo. So they wrote an editorial!
Right up front, we get the "I'm not biased, you're biased!" accusation
It's pretty rich for authors who literally worked for and actively own stock in OrthogenRx (a purveyor of fine hyaluronic acid) accuse others of "bias"
Oh, also, OrthogenRx "funded" this editorial
Really - who needs funding to write an editorial? It's like 1200 words and a figure. I've written tweetorials that long while driving
I suppose it was nice to have AOIC LLC, which OrthogenRx funded, make your figure, edit your paper, add refs, and submit the article
This sentence goes down in the #EBM pantheon
The day I spend time reading a "metaanalysis of 12 overlapping metaanalyses" is the day I quite medicine and start up a snake oil company
What does it even mean to meta analyze a dozen meta analyses?
Really though I'm thankful to AOIC LLC for the figure they made
Mostly because I'm proud of the ACR for standing up for #EBM
It aptly illustrates how much courage that takes and how divergent the conclusions of a guideline committee that relies on EBM can be
Kudos ACR.
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.